BSE filing, NSE: SOUTHMG. Summary written from the filing by ALFA Finder's alert engine.
Southern Magnesium & Chemicals Ltd: key numbers
- Share price
- ₹67.02
- Market cap
- ₹20.11 Cr
- Revenue (annual)
- ₹3.36 Cr
- Net profit (annual)
- ₹0.13 Cr
- P/E (TTM)
- -73.2×Sector 16.9×
- Promoter holding
- 50.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Southern Magnesium & Chemicals Ltd
All →Southern Magnesium & Chemicals Legal & Regulatory
Southern Magnesium and Chemicals Ltd announced the conclusion of tax proceedings by the Special Circle, Rajamahendravaram, resulting in zero tax demand on the company.
Southern Magnesium & Chemicals Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Southern Magnesium & Chemicals Management Change
Shareholders of Southern Magnesium & Chemicals Ltd rejected the redesignation of Mr. Nuthakki Rajender Prasad. He continues in his current roles as Joint Managing Director and CFO.
Southern Magnesium & Chemicals Annual General Meeting
Southern Magnesium & Chemicals Limited held its 40th Annual General Meeting on 30.09.2026 via video conferencing. Voting results will be submitted separately.
Southern Magnesium & Chemicals Annual General Meeting
Southern Magnesium and Chemicals Limited will hold its 40th AGM on September 30, 2026. The meeting will be conducted via video conferencing to transact business matters.
Southern Magnesium & Chemicals Q1 FY27 Results: Net Loss of ₹0.5 Cr, Loss Widens
Southern Magnesium & Chemicals Ltd reported revenue from operations of ₹0.3 Cr (+50.0% YoY) and a net loss of ₹0.5 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.5 Cr
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.